+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceutical Cold Chain Third Party Logistics Market Forecast to 2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2025
  • Region: Global
  • Grand View Research
  • ID: 6189433
REQUEST CUSTOMIZATION
Description Jump to:
The global biopharmaceutical cold chain third party logistics market size was estimated at USD 30.59 billion in 2024 and is projected to reach USD 74.46 billion by 2033, growing at a CAGR of 10.54% from 2025 to 2033. This market growth is due to the rising demand for temperature-sensitive pharmaceuticals, stringent drug storage and transportation regulatory requirements, and the global expansion of biologics and vaccine distribution.

In addition, increasing outsourcing of logistics services by pharmaceutical companies is further driving market expansion. Furthermore, increasing demand for biologics, vaccines, and temperature-sensitive drugs has significantly expanded the need for reliable cold chain logistics solutions. Biologics, including monoclonal antibodies, gene therapies, and recombinant proteins, require stringent temperature control, typically between 2°C and 8°C, with some requiring ultra-low storage at -70°C or lower-to maintain their efficacy.

Moreover, the growing trend towards personalized medicine has further boosted the need for specialized logistics solutions to ensure product integrity throughout the supply chain.

Global Biopharmaceutical Cold Chain Third Party Logistics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global biopharmaceutical cold chain third party logistics market based on service, temperature range, and region:

Services Outlook (Revenue, USD Million, 2021-2033)

  • Transportation
  • Warehousing & Storage
  • Packaging Solutions
  • Monitoring & Visibility Solutions
  • Inventory Management
  • Others

Temperature Range Outlook (Revenue, USD Million, 2021-2033)

  • Frozen
  • Ultra-frozen/Deep-Frozen
  • Cryogenic

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Analysis
1.3.1. Market Formulation & Data Visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Technological Landscape
3.5. Pricing Model Analysis
3.6. Industry Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Biopharmaceutical Cold Chain Third Party Logistics Market: Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Biopharmaceutical Cold Chain Third Party Logistics Market: Service Movement Analysis
4.3. Biopharmaceutical Cold Chain Third Party Logistics Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
4.4. Transportation
4.4.1. Transportation market estimates and forecasts 2021-2033 (USD Million)
4.4.2. Air Freight
4.4.2.1. Air Freight market estimates and forecasts 2021-2033 (USD Million)
4.4.3. Sea Freight
4.4.3.1. Sea Freight market estimates and forecasts 2021-2033 (USD Million)
4.4.4. Overland
4.4.4.1. Overland market estimates and forecasts 2021-2033 (USD Million)
4.5. Warehousing & Storage
4.5.1. Warehousing & Storage market estimates and forecasts 2021-2033 (USD Million)
4.6. Packaging Solutions
4.6.1. Packaging Solutions market estimates and forecasts 2021-2033 (USD Million)
4.7. Monitoring & Visibility Solutions
4.7.1. Monitoring & Visibility Solutions market estimates and forecasts 2021-2033 (USD Million)
4.8. Inventory Management
4.8.1. Inventory Management market estimates and forecasts 2021-2033 (USD Million)
4.9. Others
4.9.1. Others market estimates and forecasts 2021-2033 (USD Million)
Chapter 5. Biopharmaceutical Cold Chain Third Party Logistics Market: Temperature Range Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biopharmaceutical Cold Chain Third Party Logistics Market: Temperature Range Movement Analysis
5.3. Biopharmaceutical Cold Chain Third Party Logistics Size & Trend Analysis, by Temperature Range, 2021 to 2033 (USD Million)
5.4. Frozen
5.4.1. Frozen market estimates and forecasts 2021-2033 (USD Million)
5.4.2. Ultra-frozen/Deep-Frozen
5.4.2.1. Ultra-frozen/Deep-Frozen market estimates and forecasts 2021-2033 (USD Million)
5.4.3. Cryogenic
5.4.3.1. Cryogenic market estimates and forecasts 2021-2033 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Regional Dashboard
6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
6.3. North America
6.3.1. North America Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.3.2. U.S.
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.4. Europe
6.4.1. Europe Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.4.2. Germany
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Germany Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.4.3. UK
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. UK Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Denmark Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Sweden Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.5. Asia-Pacific
6.5.1. Asia-Pacific Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.5.5. South Korea
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. South Korea Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.5.6. Australia
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Australia Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.5.7. Thailand
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Thailand Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.6. Latin America
6.6.1. Latin America Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.7. MEA
6.7.1. MEA Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Saudi Arabia Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. UAE Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.7.6. Oman
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Oman Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
6.7.7. Qatar
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Qatar Biopharmaceutical Cold Chain Third Party Logistics market, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Position Analysis, 2024
7.3. Company Profiles
7.3.1. Cardinal Health
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Service benchmarking
7.3.1.4. Strategic initiatives
7.3.2. DHL Group
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Service benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Agility
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Service benchmarking
7.3.3.4. Strategic initiatives
7.3.4. SF Express
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Service benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Kinesis Medical B.V.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Service benchmarking
7.3.5.4. Strategic initiatives
7.3.6. United Parcel Service of America, Inc.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Service benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Barrett Distribution
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Service benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Cencora
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Service benchmarking
7.3.8.4. Strategic initiatives
7.3.9. DB Schenker
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Service benchmarking
7.3.9.4. Strategic initiatives
7.3.10. FedEx
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Service benchmarking
7.3.10.4. Strategic initiatives
7.3.11. KUEHNE + NAGEL
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Service benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Kerry Logistics Network Ltd
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Service benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Freight Logistics Solutions
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Service benchmarking
7.3.13.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 4 Global Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 5 Global Biopharmaceutical Cold Chain Third Party Logistics Market, by Region, 2021-2033 (USD Million)
Table 6 North America Biopharmaceutical Cold Chain Third Party Logistics Market, by Country, 2021-2033 (USD Million)
Table 7 North America Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 8 North America Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 9 U.S. Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 10 U.S. Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 11 Canada Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 12 Canada Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 13 Mexico Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 14 Mexico Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 15 Europe Biopharmaceutical Cold Chain Third Party Logistics Market, by Country, 2021-2033 (USD Million)
Table 16 Europe Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 17 Europe Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 18 UK Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 19 UK Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 20 Germany Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 21 Germany Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 22 France Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 23 France Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 24 Italy Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 25 Italy Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 26 Spain Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 27 Spain Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 28 Denmark Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 29 Denmark Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 30 Sweden Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 31 Sweden Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 32 Norway Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 33 Norway Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 34 Asia-Pacific Biopharmaceutical Cold Chain Third Party Logistics Market, by Country, 2021-2033 (USD Million)
Table 35 Asia-Pacific Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 36 Asia-Pacific Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 37 Japan Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 38 Japan Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 39 China Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 40 China Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 41 India Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 42 India Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 43 Australia Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 44 Australia Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 45 South Korea Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 46 South Korea Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 47 Thailand Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 48 Thailand Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 49 Latin America Biopharmaceutical Cold Chain Third Party Logistics Market, by Country, 2021-2033 (USD Million)
Table 50 Latin America Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 51 Latin America Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 52 Brazil Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 53 Brazil Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 54 Argentina Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 55 Argentina Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 56 MEA Biopharmaceutical Cold Chain Third Party Logistics Market, by Country, 2021-2033 (USD Million)
Table 57 MEA Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 58 MEA Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 59 South Africa Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 60 South Africa Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 61 Saudi Arabia Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 62 Saudi Arabia Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 63 UAE Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 64 UAE Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 65 Kuwait Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 66 Kuwait Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 67 Oman Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 68 Oman Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
Table 69 Qatar Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021-2033 (USD Million)
Table 70 Qatar Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Biopharmaceutical Cold Chain Third Party Logistics Market Segmentation
Figure 7 Market Snapshot, 2024
Figure 8 Market Trends & Outlook
Figure 9 Market Driver Relevance Analysis (Current & Future Impact)
Figure 10 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 11 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
Figure 12 Porter’s Five Forces Analysis
Figure 13 Global Biopharmaceutical Cold Chain Third Party Logistics Market: Service Key Takeaways
Figure 14 Global Biopharmaceutical Cold Chain Third Party Logistics Market: Service Movement Analysis
Figure 15 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Transportation, 2021-2033 (USD Million)
Figure 16 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Air Freight, 2021-2033 (USD Million)
Figure 17 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Sea Freight, 2021-2033 (USD Million)
Figure 18 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Overland, 2021-2033 (USD Million)
Figure 19 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Warehousing & Storage, 2021-2033 (USD Million)
Figure 20 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Packaging Solutions, 2021-2033 (USD Million)
Figure 21 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Monitoring & Visibility Solutions, 2021-2033 (USD Million)
Figure 22 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Inventory Management, 2021-2033 (USD Million)
Figure 23 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Others, 2021-2033 (USD Million)
Figure 24 Global Biopharmaceutical Cold Chain Third Party Logistics Market: Temperature Range Key Takeaways
Figure 25 Global Biopharmaceutical Cold Chain Third Party Logistics Market, Temperature Range Movement Analysis
Figure 26 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Frozen, 2021-2033 (USD Million)
Figure 27 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Ultra-frozen/Deep-Frozen, 2021-2033 (USD Million)
Figure 28 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Cryogenic, 2021-2033 (USD Million)
Figure 29 Regional Marketplace: Key Takeaways
Figure 30 Regional Outlook, 2024 & 2033
Figure 31 North America Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 32 U.S. Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 33 Canada Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 34 Mexico Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 35 Europe Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 36 Germany Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 37 UK Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 38 France Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 39 Italy Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 40 Spain Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 41 Denmark Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 42 Sweden Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 43 Norway Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 44 Asia-Pacific Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 45 Japan Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 46 China Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 47 India Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 48 Australia Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 49 South Korea Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 50 Thailand Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 51 Latin America Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 52 Brazil Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 53 Argentina Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 54 Middle East and Africa Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 55 South Africa Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 56 Saudi Arabia Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 57 UAE Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 58 Kuwait Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 59 Oman Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)
Figure 60 Qatar Biopharmaceutical Cold Chain Third Party Logistics Market, 2021-2033 (USD Million)

Companies Mentioned

The companies profiled in this Biopharmaceutical Cold Chain Third Party Logistics market report include:
  • Cardinal Health
  • DHL Group
  • Agility
  • SF Express
  • Kinesis Medical B.V.
  • United Parcel Service of America, Inc.
  • Barrett Distribution
  • Cencora
  • DB Schenker
  • FedEx
  • KUEHNE + NAGEL
  • Kerry Logistics Network Ltd.
  • Freight Logistics Solutions

Table Information

Report AttributeDetails
No. of Pages150
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 30.59 Billion
Forecasted Market Value ( USD ) by 2033 $ 74.46 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

United States Cell and Gene Therapy Third-Party Logistics Market Report by Type, Product, Therapeutic Area, End Use, States and Company Analysis, 2025-2033 - Product Image

United States Cell and Gene Therapy Third-Party Logistics Market Report by Type, Product, Therapeutic Area, End Use, States and Company Analysis, 2025-2033

  • Report
  • 200 Pages
  • United States
From
U.S. Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report by Supply Chain (Cold Chain, Non-cold Chain), Service (Transportation, Warehousing & Storage), Product (Specialty Drugs, Plasma Derived Products), and Segment Forecasts, 2025-2030 - Product Image

U.S. Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report by Supply Chain (Cold Chain, Non-cold Chain), Service (Transportation, Warehousing & Storage), Product (Specialty Drugs, Plasma Derived Products), and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • United States
From
Cell and Gene Therapy Third-Party Logistics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Cell and Gene Therapy Third-Party Logistics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Healthcare Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report by Service (Warehousing & Storage, Packaging Solutions), Product (Biopharmaceuticals), Temperature Range, End Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Healthcare Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report by Service (Warehousing & Storage, Packaging Solutions), Product (Biopharmaceuticals), Temperature Range, End Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain Logistics, Non-cold Chain Logistics), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain Logistics, Non-cold Chain Logistics), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.